These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9639415)
21. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation. Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303 [TBL] [Abstract][Full Text] [Related]
22. Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes. Schouten HC; Delwel R; Bot FJ; Hagemeijer A; Touw IP; Löwenberg B Leuk Res; 1989; 13(3):245-51. PubMed ID: 2785235 [TBL] [Abstract][Full Text] [Related]
23. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525 [TBL] [Abstract][Full Text] [Related]
24. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome. Aoki I; Higashi K; Homori M; Chikazawa H; Ishikawa K Am J Hematol; 1990 Sep; 35(1):6-12. PubMed ID: 2389770 [TBL] [Abstract][Full Text] [Related]
25. Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand. Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B Leuk Res; 1993 Sep; 17(9):799-807. PubMed ID: 7690436 [TBL] [Abstract][Full Text] [Related]
26. Identification of CD13+CD36+ cells as a common progenitor for erythroid and myeloid lineages in human bone marrow. Chen L; Gao Z; Zhu J; Rodgers GP Exp Hematol; 2007 Jul; 35(7):1047-55. PubMed ID: 17588473 [TBL] [Abstract][Full Text] [Related]
27. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. Boultwood J; Pellagatti A; Nikpour M; Pushkaran B; Fidler C; Cattan H; Littlewood TJ; Malcovati L; Della Porta MG; Jädersten M; Killick S; Giagounidis A; Bowen D; Hellström-Lindberg E; Cazzola M; Wainscoat JS PLoS One; 2008 Apr; 3(4):e1970. PubMed ID: 18398482 [TBL] [Abstract][Full Text] [Related]
28. [EPO mediated proliferation and differentiation of human erythroid progenitor inhibited by FK228]. Yu ZC; Liu WC; Fan L; Oishi K; Katayama N Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):575-7. PubMed ID: 17553359 [TBL] [Abstract][Full Text] [Related]
29. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum. Muller EW; de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E Exp Hematol; 1993 Sep; 21(10):1353-7. PubMed ID: 7689483 [TBL] [Abstract][Full Text] [Related]
30. Purification, amplification and characterization of a population of human erythroid progenitors. Freyssinier JM; Lecoq-Lafon C; Amsellem S; Picard F; Ducrocq R; Mayeux P; Lacombe C; Fichelson S Br J Haematol; 1999 Sep; 106(4):912-22. PubMed ID: 10519992 [TBL] [Abstract][Full Text] [Related]
31. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Backx B; Broeders L; Löwenberg B Blood; 1992 Sep; 80(5):1213-7. PubMed ID: 1381239 [TBL] [Abstract][Full Text] [Related]
32. In vitro proliferation and differentiation of erythroid progenitors of cord blood. Sakatoku H; Inoue S Stem Cells; 1997; 15(4):268-74. PubMed ID: 9253110 [TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid. Rogers CE; Bradley MS; Palsson BO; Koller MR Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964 [TBL] [Abstract][Full Text] [Related]
34. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions. Zauli G; Vitale M; Visani G; Marchisio M; Milani D; Capitani S Br J Haematol; 1994 Mar; 86(3):461-7. PubMed ID: 7519034 [TBL] [Abstract][Full Text] [Related]
36. [Effect of angiotensin II on cord blood CD34(+) cells expansion in vitro]. Peng C; Li WM; Ma YP; Hu ZB; Cheng FJ; Liu LB; Zou P Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):227-9. PubMed ID: 12844400 [TBL] [Abstract][Full Text] [Related]
37. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions--comparison to other cytokines and growth factors. Ratajczak J; Zhang Q; Pertusini E; Wojczyk BS; Wasik MA; Ratajczak MZ Leukemia; 1998 Mar; 12(3):371-81. PubMed ID: 9529132 [TBL] [Abstract][Full Text] [Related]
38. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis. Kawano Y; Takaue Y; Hirao A; Sato J; Abe T; Suzue T; Saito S; Okamoto Y; Kuroda Y Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591 [TBL] [Abstract][Full Text] [Related]
39. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861 [TBL] [Abstract][Full Text] [Related]
40. Action of human interleukin-4 and stem cell factor on erythroid and mixed colony formation by peripheral blood-derived CD34+ c-kit(high) or CD34+ c-kit(low) cells. Sonoda Y; Kimura T; Ohmizono Y; Sakabe H; Tanimukai S; Yokota S; Clark SC; Abe T Br J Haematol; 1997 Mar; 96(4):781-9. PubMed ID: 9074422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]